Literature DB >> 26725090

Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients.

Sini Hiltunen1,2, Jukka Putaala3, Elena Haapaniemi3, Turgut Tatlisumak3,4,5.   

Abstract

Cerebral venous thrombosis (CVT) affects mainly working-aged individuals. Functional recovery after CVT is generally considered good with about 3/4 of patients achieving short-term independence. However, vascular events, long-term functional outcome, and employment after CVT remain poorly investigated. We identified consecutive adult CVT patients treated at the Helsinki University Hospital (1987-2013) and invited them to a follow-up visit. Each clinical examination was combined with interview. We also recorded recurrent venous thromboembolism (VTE) and hemorrhagic events during follow-up and antithrombotic medication use. A modified Rankin Scale (mRS) served to assess functional outcome. Logistic regression served to identify independent factors associated with unemployment and functional recovery. Of the 195 patients identified, 21 died, 9 declined to participate, and 4 were excluded from the study. Thus, 161 patients (106 women) underwent an examination after a median of 39 months (interquartile range 14-95). VTE (one of which was CVT) occurred in 9 (6%) patients, and severe hemorrhagic events in 10 (6%). Functional outcome was good, with 84% scoring 0-1 on the mRS; 42% reported residual symptoms. Altogether, 91 (57%) patients were employed. After adjusting for age and sex, a National Institutes of Health Stroke Scale score>2 at admission and low education level, associated with both unfavorable functional outcome and unemployment. Long-term functional outcome after CVT may appear good if measured with mRS, but patients often have residual symptoms and are frequently unable to return to their previous work.

Entities:  

Keywords:  Anticoagulation; Cerebral venous thrombosis; Follow-up; Long-term outcome; Sinus thrombosis; Vocational status

Mesh:

Substances:

Year:  2016        PMID: 26725090     DOI: 10.1007/s00415-015-7996-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.

Authors:  John Simes; Cecilia Becattini; Giancarlo Agnelli; John W Eikelboom; Adrienne C Kirby; Rebecca Mister; Paolo Prandoni; Timothy A Brighton
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

2.  Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Paolo Bucciarelli; Serena M Passamonti; Tullia Battaglioli; Emanuele Previtali; Pier Mannuccio Mannucci
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

3.  Recanalization and its correlation to outcome after cerebral venous thrombosis.

Authors:  Jukka Putaala; Sini Hiltunen; Oili Salonen; Markku Kaste; Turgut Tatlisumak
Journal:  J Neurol Sci       Date:  2010-03-04       Impact factor: 3.181

4.  Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival.

Authors:  I Gosk-Bierska; W Wysokinski; R D Brown; K Karnicki; D Grill; H Wiste; E Wysokinska; R D McBane
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

5.  Obstetrical outcome of young women with a past history of cerebral venous thrombosis.

Authors:  Jonathan Ciron; Gaëlle Godenèche; Xavier Vandamme; Marie-Pierre Rosier; Igor Sharov; Stéphane Mathis; Delphine Larrieu; Jean-Philippe Neau
Journal:  Cerebrovasc Dis       Date:  2013-07-30       Impact factor: 2.762

6.  Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis.

Authors:  S F de Bruijn; M Budde; S Teunisse; R J de Haan; J Stam
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

7.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

8.  Long-term sequelae after cerebral venous thrombosis in functionally independent patients.

Authors:  Karen Koopman; Maarten Uyttenboogaart; Patrick C Vroomen; Jan van der Meer; Jacques De Keyser; Gert-Jan Luijckx
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 May-Jun       Impact factor: 2.136

9.  Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients.

Authors:  M Preter; C Tzourio; A Ameri; M G Bousser
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

10.  Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients.

Authors:  G Breteau; F Mounier-Vehier; O Godefroy; J-Y Gauvrit; M-A Mackowiak-Cordoliani; M Girot; D Bertheloot; H Hénon; C Lucas; X Leclerc; F Fourrier; J P Pruvo; D Leys
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

View more
  16 in total

Review 1.  [Ability to drive with cerebrovascular diseases : Position paper of the German societies DGNB, DGN, DGNC, DGNR, DSG and GNP].

Authors:  P Marx; G F Hamann; O Busse; T Mokrusch; H Niemann; H Vatter; B Widder
Journal:  Nervenarzt       Date:  2019-04       Impact factor: 1.214

2.  Safety of pregnancy after cerebral venous thrombosis: systematic review update.

Authors:  Diana Aguiar de Sousa; Patrícia Canhão; José M Ferro
Journal:  J Neurol       Date:  2017-11-13       Impact factor: 4.849

Review 3.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

4.  Risk of Pulmonary Embolism After Cerebral Venous Thrombosis.

Authors:  Ava L Liberman; Alexander E Merkler; Gino Gialdini; Steven R Messé; Michael P Lerario; Santosh B Murthy; Hooman Kamel; Babak B Navi
Journal:  Stroke       Date:  2017-02-22       Impact factor: 7.914

5.  Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department.

Authors:  Ava L Liberman; Gino Gialdini; Ekaterina Bakradze; Abhinaba Chatterjee; Hooman Kamel; Alexander E Merkler
Journal:  Stroke       Date:  2018-04-25       Impact factor: 7.914

Review 6.  Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review.

Authors:  Yaxi Luo; Xin Tian; Xuefeng Wang
Journal:  Front Aging Neurosci       Date:  2018-01-30       Impact factor: 5.750

7.  Epidemiology, Endovascular Treatment, and Prognosis of Cerebral Venous Thrombosis: US Center Study of 152 Patients.

Authors:  Kristin Salottolo; Jeffrey Wagner; Donald F Frei; David Loy; Richard J Bellon; Kathryn McCarthy; Judd Jensen; Christopher Fanale; David Bar-Or
Journal:  J Am Heart Assoc       Date:  2017-06-13       Impact factor: 5.501

8.  Clinical features of seizures after cerebral venous sinus thrombosis and its effect on outcome among Chinese Han population.

Authors:  Hongyan Ding; Yanan Xie; Linxin Li; Heling Chu; Yuping Tang; Qiang Dong; Mei Cui
Journal:  Stroke Vasc Neurol       Date:  2017-08-27

9.  Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis.

Authors:  Kangxiang Ji; Longfei Wu; Wenbo Zhao; Chuanjie Wu; Yaoming Xu; Jiangang Duan; Ran Meng; Feng Yan; Jian Chen; Di Wu; Yinghao Luo; Xunming Ji
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

10.  Spectrum of Cerebral Venous Thrombosis in Oman.

Authors:  Darshan Lal; Arunodaya R Gujjar; Nandagopal Ramachandiran; Ammar Obaidi; Sunil Kumar; Mortada El-Tigani; Faizal Al-Azri; Abdullah R Al-Asmi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.